June 2, 2020 Circulation. 2020; 141: 1739–1741. DOI: 10.1161/CIRCULATIONAHA.
120.047419 1740 nonsurvivors. Given this diffuse thrombosis, Chinese physicians …

Severe acute respiratory syndrome coronavirus 2 is responsible for the current COVID-19
pandemic resulting in an escalating number of cases and fatalities worldwide. Preliminary …

Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily
Keywords: complement; complement inhibition; COVID-19; thrombotic microangiopathy EN …

In December 2019, the world was introduced to a new betacoronavirus, referred to as
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) for its propensity to cause …

COVID‐19 is frequently accompanied by a hypercoagulable inflammatory state with
microangiopathic pulmonary changes that can precede the diffuse alveolar damage …

Acute respiratory failure and a systemic coagulopathy are critical aspects of the morbidity
and mortality characterizing infection with severe acute respiratory distress syndrome …

Hyperactivation of the complement and coagulation systems is recognized as part of the
clinical syndrome of COVID-19. Here we review systemic complement activation and local …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious
respiratory virus that can lead to venous/arterial thrombosis, stroke, renal failure, myocardial …

In a stunningly short period of time, the unexpected coronavirus disease 2019 (COVID-19)
pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2), has …

Abstract Coronavirus disease of 2019 (COVID-19) is a highly contagious respiratory
infection that is caused by the severe acute respiratory syndrome coronavirus 2. Although …